BridgeBio has demonstrably improved this development of a innovative solution for cardiac amyloidosis, utilizing Attruby. Initial clinical data indicates significant benefits for patients diagnosed with this https://attrcm883117.blogzet.com/company-progresses-cardiac-amyloidosis-treatment-using-attruby-57245194